Language selection

Search


Tradename information - 51621000087101

View tradename immunizing agents subset

Concept details

[COVID-19] COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.2 mL


Pan-Canadian SNOMED CT terminology

Concept code
51621000087101
Concept status
active
Version
20240229
Display name
English: [COVID-19] COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.2 mL
French: [COVID-19] COMIRNATY Omicron XBB.1.5 pédiatrique 10 mcg/0.2 mL
Abbreviation
English: COVID-19
French: COVID-19
Fully specified name
COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug)
Market authorization holder
BIONTECH MANUFACTURING GMBH

Health Canada drug information

Select the DIN below to go directly to the product monograph on the Health Canada website

Drug Identification Number Product status Strength Typical dose
02541831 Cancelled Pre Market 10 MCG 0.2 ML

Linked product data

Lot numbers
  • not available

Linked concepts

This vaccine protects against the following diseases:

This vaccine contains the following antigens:


National Vaccine Catalogue database details

Last updated
2025-03-06

Concept history

This concept replaces

Market Authorization Holder Concept History
Concept code Display name
No data is available

Notice

Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.

Disclaimer

The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.

Version:
1.0.12